
AesculaTech
AesculaTech is a YC Winter 2018 (W18) company. Based in Los Angeles, CA, USA. Team of 6.
About AesculaTech
Summary
AesculaTech engineers proprietary smart hydrogels that change properties in response to temperature and other stimuli, then builds those materials into biomedical, industrial, and cosmetic products. Its lead product, Humidifeye, is a punctal plug for dry eye disease: a form-fitting smart gel that seats in the tear duct, adapts to the patient's anatomy, and replaces conventional rigid plugs that can extrude or cause discomfort. The platform is also being developed for high-strength films and next-generation composites across medical, industrial, and cosmetic applications.
Go-to-market
AesculaTech targets ophthalmology patients and clinicians with Humidifeye, which is currently in investigational use pending FDA clearance; broader material platform opportunities are pursued through partnerships across medical, industrial, and cosmetic sectors.
From the Y Combinator listing
Responsive materials, better lives.
AesculaTech believes in building better lives through smart chemistry. We design custom smart materials for a range of biomedical, commercial, and industrial applications. Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes. Founded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Though Humidifeye is not yet FDA approved, expect to hear about it soon! In coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision. This work has already been recognized. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs. In short, Y-Combinator was only the beginning.
Facts
- Healthcare / Healthcare -> Medical Devices
- Los Angeles, CA, USA
- 6
- Active
- Early
Founders (1)
- Niki Bayat
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works